Margherita Cerone1, Marco Tofani2, Giovanni Fabbrini3,4, Giulia Marcellini5, Anna Berardi3, Claudia Conti5, Rita De Santis6, Donatella Valente3,4, Giovanni Galeoto3,4. 1. San Giovanni Battista-Cavalieri di Malta, Rome, Italy. 2. Neurorehabilitation Unit, Department of Intensive Neurorehabilitation and Robotics, Bambino Gesù Children's Hospital, Italy. 3. Department of Human Neurosciences, Sapienza University of Rome, Italy. 4. IRCCS Neuromed Pozzilli, Italy. 5. Sapienza University of Rome, Rome, Italy. 6. Department of Anatomical, Histological, Forensic and Orthopedic Sciences, "Sapienza" University of Rome, Italy.
Abstract
PURPOSE: This study is aimed at validating the A-ONE scale in an Italian population with Central Nervous System (CNS) dysfunction. Material and Methods. Between May and November 2018, people aged between 60 and 90 with CNS dysfunction were recruited in a hospital in Rome, Italy. Patients were observed and evaluated during the activities of daily living. Internal consistency and reliability were evaluated with Cronbach's coefficient alpha and intraclass correlation coefficient, respectively. As measured with Pearson's correlation coefficient, the validity was examined comparing results of the A-ONE with the Barthel index. Responsiveness was evaluated 30 days after the first administration. RESULTS: A total of 70 people having a diagnosis of neurological disorders were evaluated. The internal consistency showed Cronbach's coefficient alpha ranging from 0.634 to 0.959. The measurement of reliability varied from 0.984 to 0.997 for intrarater and from 0.979 to 0.998 for interrater. Pearson's correlation coefficient between the A-ONE and the Barthel index and the responsiveness showed statistically significant values (p < 0.01). CONCLUSIONS: The present study provides preliminary evidence of reliability, validity, and responsiveness of the A-ONE when using elderly people with CNS dysfunction.
PURPOSE: This study is aimed at validating the A-ONE scale in an Italian population with Central Nervous System (CNS) dysfunction. Material and Methods. Between May and November 2018, people aged between 60 and 90 with CNS dysfunction were recruited in a hospital in Rome, Italy. Patients were observed and evaluated during the activities of daily living. Internal consistency and reliability were evaluated with Cronbach's coefficient alpha and intraclass correlation coefficient, respectively. As measured with Pearson's correlation coefficient, the validity was examined comparing results of the A-ONE with the Barthel index. Responsiveness was evaluated 30 days after the first administration. RESULTS: A total of 70 people having a diagnosis of neurological disorders were evaluated. The internal consistency showed Cronbach's coefficient alpha ranging from 0.634 to 0.959. The measurement of reliability varied from 0.984 to 0.997 for intrarater and from 0.979 to 0.998 for interrater. Pearson's correlation coefficient between the A-ONE and the Barthel index and the responsiveness showed statistically significant values (p < 0.01). CONCLUSIONS: The present study provides preliminary evidence of reliability, validity, and responsiveness of the A-ONE when using elderly people with CNS dysfunction.
Authors: G Galeoto; M C Formica; N B Mercuri; Valter Santilli; Anna C Berardi; S F Castiglia; R Mollica; A Servadio Journal: Funct Neurol Date: 2019 Jan-Mar
Authors: Lynn A Legg; Sharon R Lewis; Oliver J Schofield-Robinson; Avril Drummond; Peter Langhorne Journal: Cochrane Database Syst Rev Date: 2017-07-19